EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy

Benjamin Meder iD, Caroline J Coats, Leslie A Leinwand, Maurizio Pieroni, Pablo Garcia-Pavia iD, Milind Y Desai iD, Farbod Sedaghat-Hamedani

European Journal of Heart Failure · 11.05.2026 · 28 (2) · 299-314

DOI: 10.1093/ejhf/xuaf008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 08.01.2026. Verfasst von Benjamin Meder und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology and Pulmonology, Institut für Cardiomyopathien Heidelberg, University of Heidelberg, INF 410, Im Neuenheimer Feld…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Death, Sudden, Cardiac, Disease Management. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic cardiac disease and a leading cause of heart failure, arrhythmia, and sudden cardiac death in both young and older adults. This consensus document was developed by a multidisciplinary panel of European and U.S. experts in HCM, imaging, electrophysiology, genetics, and heart failure. While it aligns with the 2023 ESC and 2024 AHA/ACC guidelines on HCM, the paper addresses areas where clinicians might require further guidance. Key sections include phenotypic classification, diagnostic strategies incorporating multimodal imaging and genetic testing, and risk stratification for sudden cardiac death. The document outlines therapeutic pathways for pharmacologic treatment, including beta-blockers, calcium channel blockers, disopyramide, and cardiac myosin inhibitors such as mavacamten and aficamten, as well as indications for septal reduction therapies. Management of atrial fibrillation, hypertension, coronary artery disease, pregnancy, paediatric HCM, and comorbidities is discussed in detail. Importantly, the consensus addresses current controversies including optimal risk stratification models, the care of genotype-positive/phenotype-negative individuals, and exercise recommendations. Finally, the manuscript highlights future directions such as gene therapy, precision medicine approaches, use of artificial intelligence and novel biomarkers for screening and diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicDeath, Sudden, CardiacDisease ManagementHumansGenetic Testing

Stichwörter der Autor:innen

Consensus recommendationsHypertrophic cardiomyopathyMyosin inhibitorsNon-obstructive HCMObstructive HCMSeptal reduction therapy

Autor:innen und Institutionen

  • Department of Cardiology, Angiology and Pulmonology, Institut für Cardiomyopathien Heidelberg, University of Heidelberg, INF 410, Im Neuenheimer Feld 410, Heidelberg 69120, Germany.
  • German Center for Cardiovascular Research (DZHK) Partnerside Heidelberg, Heidelberg, Germany.
  • Precision Digital Health and Informatics for Life, Department of Cardiology, Angiology and Pulmonology, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany.
  • School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO, USA.
  • Molecular, Cellular, and Developmental Biology, University of Colorado at Boulder, Boulder, CO, USA.

ORCID-Profile: Benjamin Meder, Pablo Garcia-Pavia, Milind Y Desai

Zitieren

APA

Meder, B., Coats, C. J., Leinwand, L. A., Pieroni, M., Garcia-Pavia, P., Desai, M. Y., & Sedaghat-Hamedani, F. (2026). EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy. European Journal of Heart Failure, 28(2), 299-314. https://doi.org/10.1093/ejhf/xuaf008

Vancouver

Meder B, Coats CJ, Leinwand LA, Pieroni M, Garcia-Pavia P, Desai MY, et al. EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy. European Journal of Heart Failure. 2026;28(2):299-314. doi:10.1093/ejhf/xuaf008

BibTeX
@article{Meder2026,
  author = {Meder, Benjamin and Coats, Caroline J and Leinwand, Leslie A and Pieroni, Maurizio and Garcia-Pavia, Pablo and Desai, Milind Y and Sedaghat-Hamedani, Farbod},
  title = {EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy},
  journal = {European Journal of Heart Failure},
  year = {2026},
  volume = {28},
  number = {2},
  pages = {299--314},
  doi = {10.1093/ejhf/xuaf008}
}
Kostenlos starten →